Neuroacanthocytisis from Iran- Report of Molecular and Clinical findings

Publish Year: 1396
نوع سند: مقاله کنفرانسی
زبان: English
View: 368

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

NGCMED10_112

تاریخ نمایه سازی: 16 تیر 1397

Abstract:

Neuroacanthocytosis (NA) syndromes are a group of genetically defined disorders leading to progressiveneurodegeneration of the basal ganglia and thorny appearance of erythrocytes. NA can be divided into twogroups:1)Core neuroacanthocytosis syndromes:Chorea-acanthocytosis (ChAc)McLeod syndrome (MLS)Huntington’s disease-like 2 (HDL2)Pantothenate kinase associatedneurodegeneration (PKAN; including HARP subtype)2)Neuroacanthocytosis with lipoprotein disorders:AbetalipoproteinemiaFamilial hypobetalipoproteinaemiaAnderson diseaseAtypical Wolman diseaseWe will discuss about clinical and molecular findings in two PKAN cases (with novel mutations), one HDL2,one ChAc and one Abetalipoproteinemia case (with novel mutation) in 5 unrelated family from Iranian descent.

Authors

Masoumeh Dehghan Manshadi

Medical Genetic Center, Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences (TUMS), Tehran-Iran- Departman of Molecular Medicine,Iran University of Medical Sciences, Tehran,Iran

Parvin Pishva

Medical Genetic Center, Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences (TUMS),Tehran-Iran

Hossein Adibi

Metabolomics and Genomics Research Center, Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences (TUMS), Tehran-Iran

Omid Aryani

Medical Genetic Center, Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences (TUMS), Tehran-Iran- Departman of Neuroscience,Iran University of Medical Sciences, Tehran,Iran